These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 24657164)
1. BRD7, a tumor suppressor, interacts with p85α and regulates PI3K activity. Chiu YH; Lee JY; Cantley LC Mol Cell; 2014 Apr; 54(1):193-202. PubMed ID: 24657164 [TBL] [Abstract][Full Text] [Related]
2. Direct positive regulation of PTEN by the p85 subunit of phosphatidylinositol 3-kinase. Chagpar RB; Links PH; Pastor MC; Furber LA; Hawrysh AD; Chamberlain MD; Anderson DH Proc Natl Acad Sci U S A; 2010 Mar; 107(12):5471-6. PubMed ID: 20212113 [TBL] [Abstract][Full Text] [Related]
3. The regulatory subunits of PI3K, p85α and p85β, differentially affect BRD7-mediated regulation of insulin signaling. Lee JM; Liu R; Park SW J Mol Cell Biol; 2022 Jan; 13(12):889-901. PubMed ID: 34751372 [TBL] [Abstract][Full Text] [Related]
4. Activation of PI3K/Akt signaling by n-terminal SH2 domain mutants of the p85α regulatory subunit of PI3K is enhanced by deletion of its c-terminal SH2 domain. Hofmann BT; Jücker M Cell Signal; 2012 Oct; 24(10):1950-4. PubMed ID: 22735814 [TBL] [Abstract][Full Text] [Related]
5. LZTS2 inhibits PI3K/AKT activation and radioresistance in nasopharyngeal carcinoma by interacting with p85. Xu S; Li Y; Lu Y; Huang J; Ren J; Zhang S; Yin Z; Huang K; Wu G; Yang K Cancer Lett; 2018 Apr; 420():38-48. PubMed ID: 29409973 [TBL] [Abstract][Full Text] [Related]
6. miR-141 is involved in BRD7-mediated cell proliferation and tumor formation through suppression of the PTEN/AKT pathway in nasopharyngeal carcinoma. Liu Y; Zhao R; Wang H; Luo Y; Wang X; Niu W; Zhou Y; Wen Q; Fan S; Li X; Xiong W; Ma J; Li X; Tan M; Li G; Zhou M Cell Death Dis; 2016 Mar; 7(3):e2156. PubMed ID: 27010857 [TBL] [Abstract][Full Text] [Related]
7. Src family protein-tyrosine kinases alter the function of PTEN to regulate phosphatidylinositol 3-kinase/AKT cascades. Lu Y; Yu Q; Liu JH; Zhang J; Wang H; Koul D; McMurray JS; Fang X; Yung WK; Siminovitch KA; Mills GB J Biol Chem; 2003 Oct; 278(41):40057-66. PubMed ID: 12869565 [TBL] [Abstract][Full Text] [Related]
8. Src homology domain 2-containing protein-tyrosine phosphatase-1 (SHP-1) binds and dephosphorylates G(alpha)-interacting, vesicle-associated protein (GIV)/Girdin and attenuates the GIV-phosphatidylinositol 3-kinase (PI3K)-Akt signaling pathway. Mittal Y; Pavlova Y; Garcia-Marcos M; Ghosh P J Biol Chem; 2011 Sep; 286(37):32404-15. PubMed ID: 21799016 [TBL] [Abstract][Full Text] [Related]
9. A p85 isoform switch enhances PI3K activation on endosomes by a MAP4- and PI3P-dependent mechanism. Thapa N; Chen M; Cryns VL; Anderson R Cell Rep; 2024 May; 43(5):114119. PubMed ID: 38630589 [TBL] [Abstract][Full Text] [Related]
10. BRD7 regulates XBP1s' activity and glucose homeostasis through its interaction with the regulatory subunits of PI3K. Park SW; Herrema H; Salazar M; Cakir I; Cabi S; Basibuyuk Sahin F; Chiu YH; Cantley LC; Ozcan U Cell Metab; 2014 Jul; 20(1):73-84. PubMed ID: 24836559 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of PI3K binding to activators by serine phosphorylation of PI3K regulatory subunit p85alpha Src homology-2 domains. Lee JY; Chiu YH; Asara J; Cantley LC Proc Natl Acad Sci U S A; 2011 Aug; 108(34):14157-62. PubMed ID: 21825134 [TBL] [Abstract][Full Text] [Related]
12. Balanced interactions between Lyn, the p85alpha regulatory subunit of class I(A) phosphatidylinositol-3-kinase, and SHIP are essential for mast cell growth and maturation. Ma P; Vemula S; Munugalavadla V; Chen J; Sims E; Borneo J; Kondo T; Ramdas B; Mali RS; Li S; Hashino E; Takemoto C; Kapur R Mol Cell Biol; 2011 Oct; 31(19):4052-62. PubMed ID: 21791602 [TBL] [Abstract][Full Text] [Related]
13. p85 plays a critical role in controlling flux through the PI3K/PTEN signaling axis through dual regulation of both p110 (PI3K) and PTEN. Anderson DH Cell Cycle; 2010 Jun; 9(11):2055-6. PubMed ID: 20505341 [No Abstract] [Full Text] [Related]
14. Somatic mutations in p85alpha promote tumorigenesis through class IA PI3K activation. Jaiswal BS; Janakiraman V; Kljavin NM; Chaudhuri S; Stern HM; Wang W; Kan Z; Dbouk HA; Peters BA; Waring P; Dela Vega T; Kenski DM; Bowman KK; Lorenzo M; Li H; Wu J; Modrusan Z; Stinson J; Eby M; Yue P; Kaminker JS; de Sauvage FJ; Backer JM; Seshagiri S Cancer Cell; 2009 Dec; 16(6):463-74. PubMed ID: 19962665 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of 14-3-3ζ in cancer cells activates PI3K via binding the p85 regulatory subunit. Neal CL; Xu J; Li P; Mori S; Yang J; Neal NN; Zhou X; Wyszomierski SL; Yu D Oncogene; 2012 Feb; 31(7):897-906. PubMed ID: 21743495 [TBL] [Abstract][Full Text] [Related]
16. Regulation of the PI3K pathway through a p85α monomer-homodimer equilibrium. Cheung LW; Walkiewicz KW; Besong TM; Guo H; Hawke DH; Arold ST; Mills GB Elife; 2015 Jul; 4():e06866. PubMed ID: 26222500 [TBL] [Abstract][Full Text] [Related]
17. Human oncoprotein MDM2 activates the Akt signaling pathway through an interaction with the repressor element-1 silencing transcription factor conferring a survival advantage to cancer cells. Singh S; Ramamoorthy M; Vaughan C; Yeudall WA; Deb S; Palit Deb S Cell Death Differ; 2013 Apr; 20(4):558-66. PubMed ID: 23238568 [TBL] [Abstract][Full Text] [Related]
18. High frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer elucidates a novel mechanism for regulation of PTEN protein stability. Cheung LW; Hennessy BT; Li J; Yu S; Myers AP; Djordjevic B; Lu Y; Stemke-Hale K; Dyer MD; Zhang F; Ju Z; Cantley LC; Scherer SE; Liang H; Lu KH; Broaddus RR; Mills GB Cancer Discov; 2011 Jul; 1(2):170-85. PubMed ID: 21984976 [TBL] [Abstract][Full Text] [Related]
19. The p85 regulatory subunit of phosphoinositide 3-kinase down-regulates IRS-1 signaling via the formation of a sequestration complex. Luo J; Field SJ; Lee JY; Engelman JA; Cantley LC J Cell Biol; 2005 Aug; 170(3):455-64. PubMed ID: 16043515 [TBL] [Abstract][Full Text] [Related]
20. Mechanism of constitutive phosphoinositide 3-kinase activation by oncogenic mutants of the p85 regulatory subunit. Shekar SC; Wu H; Fu Z; Yip SC; Nagajyothi ; Cahill SM; Girvin ME; Backer JM J Biol Chem; 2005 Jul; 280(30):27850-5. PubMed ID: 15932879 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]